Fever management with or without a temperature control device after out-of-hospital cardiac arrest and resuscitation (TEMP-CARE): A study protocol for a randomized clinical trial
Language English Country Great Britain, England Media print
Document type Clinical Trial Protocol, Journal Article
Grant support
Swedish Research Council
ALF-project funding within the Swedish Health Care
Academy of Finland
Sigrid Jusélius Foundation (Finland)
Hospital district of Helsinki and Uusimaa (Finland)
Medicinska Understödsföreningen Liv och Hälsa (Sweden)
Medical Research Future Fund (Australia)
Health Research Council of New Zealand, and the Clinical Research Programme Directorate of Health Ministry of Health and Social Security (Luxembourg)
PubMed
40222389
PubMed Central
PMC11994252
DOI
10.1111/aas.70034
Knihovny.cz E-resources
- Keywords
- cardiac arrest, feedback‐controlled device, fever, randomized controlled trial, temperature management,
- MeSH
- Fever * therapy MeSH
- Cardiopulmonary Resuscitation * MeSH
- Humans MeSH
- Multicenter Studies as Topic MeSH
- Randomized Controlled Trials as Topic MeSH
- Body Temperature MeSH
- Hypothermia, Induced * instrumentation MeSH
- Out-of-Hospital Cardiac Arrest * therapy complications MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial Protocol MeSH
BACKGROUND: Fever is associated with brain injury after cardiac arrest. It is unknown whether fever management with a feedback-controlled device impacts patient-centered outcomes in cardiac arrest patients. This trial aims to investigate fever management with or without a temperature control device after out-of-hospital cardiac arrest. METHODS: The TEMP-CARE trial is part of the 2 × 2 × 2 factorial Sedation, TEmperature and Pressure after Cardiac Arrest and REsuscitation (STEPCARE) trial, a randomized, international, multicenter, parallel-group, investigator-initiated, superiority trial that will evaluate sedation strategies, temperature management, and blood pressure targets simultaneously in nontraumatic/nonhemorrhagic out-of-hospital cardiac arrest patients following hospital admission. For the temperature management component of the trial described in this protocol, patients will be randomly allocated to fever management with or without a feedback-controlled temperature control device. For those managed with a device, if temperature ≥37.8°C occurs within 72 h post-randomization the device will be started targeting a temperature of ≤37.5°C. Standard fever treatment, as recommended by local guidelines, including pharmacological agents, will be provided to participants in both groups. The two other components of the STEPCARE trial evaluate sedation and blood pressure strategies. Apart from the STEPCARE trial interventions, all other aspects of general intensive care will be according to the local practices of the participating site. A physician blinded to the intervention will determine the neurological prognosis following European Resuscitation Council and European Society of Intensive Care Medicine guidelines. The primary outcome is all-cause mortality at six months post-randomization. To detect a 5.6% absolute risk reduction (90% power, alpha .05), 3500 participants will be enrolled. Secondary outcomes include poor functional outcome at six months, intensive care-related serious adverse events, and overall health status at six months. CONCLUSION: The TEMP-CARE trial will investigate if post-cardiac arrest management of fever with or without a temperature control device affects patient-important outcomes after cardiac arrest.
Adult Critical Care University Hospital of Wales Cardiff UK
Anesthesia and Intensive Care Department of Clinical Sciences Lund Lund University Lund Sweden
Anglia Ruskin School of Medicine and MTRC Essex UK
CEDAR Cardiff and Vale University Health Board Cardiff UK
Critical Care and Perioperative Medicine Group Queen Mary University of London London UK
Critical Care Program The George Institute for Global Health Sydney Australia
Critical Care Program The George Institute for Global Health UNSW Sydney Australia
Department of Anaesthesia and Intensive Care Central Hospital Karlstad Sweden
Department of Anaesthesia and Intensive Care Skaraborgs Sjukhus Skövde Skaraborg Sweden
Department of Anaesthesiology and Intensive Care Hallands Hospital Halmstad Halmstad Sweden
Department of Anaesthesiology and Intensive Care Helsingborg Hospital Helsingborg Sweden
Department of Anaesthesiology and Intensive Care Kuopio University Hospital
Department of Anesthesia and Intensive Care Helsingborg Hospital Helsingborg Sweden
Department of Anesthesia Critical Care and Pain Medicine Jaber Alahmad Alsabah Hospital Zahra Kuwait
Department of Cardiology Ziekenhuis Oost Limburg Genk Belgium
Department of Clinical Science Intervention and Technology Karolinska Institute Stockholm Sweden
Department of Clinical Sciences Lund Anesthesia and Intensive Care Lund University Lund Sweden
Department of Clinical Sciences Lund Lund University Lund Sweden
Department of Clinical Sciences Lund Section of Cardiology Skåne University Hospital Malmö Sweden
Department of Critical Care Medicine King's College Hospital London UK
Department of Critical Care Portsmouth University Hospitals Trust Portsmouth UK
Department of Critical Care University of Melbourne Melbourne Victoria Australia
Department of Intensive and Perioperative Care Skåne University Hospital Lund University Lund Sweden
Department of Intensive Care Christchurch Hospital Christchurch New Zealand
Department of Intensive Care Kuopio University Hospitals Kuopio Finland
Department of Intensive Care Medicine Ghent University Hospital Ghent Belgium
Department of Intensive Care Medicine Inselspital University Hospital Bern Bern Switzerland
Department of Intensive Care Medicine Stavanger University Hospital Stavanger Norway
Department of Neurology and Rehabilitation Skåne University Hospital Lund Sweden
Department of Neurology and Stroke Hertie Institute of Clinical Brain Research Tübingen Germany
Department of Neurology and Stroke University Hospital Tuebingen Tübingen Germany
Department of Neurology Charité Universitätsmedizin Berlin Berlin Germany
Department of Neurology Department of Clinical Sciences Lund Lund University Lund Sweden
Department of Neurology Helsinki University Hospital and University of Helsinki Finland
Department of Neurology Skåne University Hospital Lund Sweden
Department of Perioperative Medicine Bart's Heart Centre St Bartholomew's Hospital London UK
Department of Physiology and Pharmacology Karolinska Institutet Solna Sweden
Department of Research Development Education and Innovation Skåne University Hospital Lund Sweden
Dipartimento di Scienze Chirurgiche Diagnostiche Integrate University of Genova Genova Italy
Essex Cardiothoracic Centre MSE NHSFT Essex UK
Faculty of Medicine Charles University Prague Prague Czech Republic
Function Perioperative Medicine and Intensive Care Karolinska University Hospital Stockholm Sweden
Guy's and St Thomas' NHS Trust London UK
HUS Jorvi Hospital ICU Esbo Finland
Institute for Heart Diseases Wroclaw Medical University Wrocław Poland
Institute of Intensive Care Medicine University Hospital Zurich Zurich Switzerland
Intensive and Perioperative Care Skåne University Hospital Malmö Sweden
Intensive Care Unit Tampere University Hospital Tampere Finland
Intensive Care Unit University Hospitals Bristol and Weston Bristol
Intensive Care Unit Wellington Hospital Wellington New Zealand
Istituto Cardiocentro Ticino Lugano Lugano Switzerland
Klinik für Intensivmedizin Kantonsspital St Gallen St Gallen Switzerland
Lee Kong Chian School of Medicine Nanyang Technological University Singapore
Malcolm Fisher Department of Intensive Care Medicine Royal North Shore Hospital Sydney Australia
Medical Research Institute of New Zealand Wellington New Zealand
Medical School University of Queensland Royal Brisbane and Women's Hospital Brisbane Australia
Middlemore Hospital Auckland New Zealand
North Estonia Medical Centre Tallinn Estonia
Northern Clinical School Sydney Medical School University of Sydney Sydney Australia
OYS Heart Oulu University Hospital MRC Oulu and University of Oulu Oulu Finland
Perioperative Medicine and Intensive Care Karolinska University Hospital Stockholm Sweden
Regional Intensive Care Unit Royal Victoria Hospital Belfast UK
Royal North Shore Hospital Sydney Australia
School of Clinical Medicine Queensland University of Technology Brisbane Queensland Australia
South Western Clinical School University of New South Wales Sydney New South Wales Australia
St George's Hospital London UK
Tan Tock Seng Hospital Singapore
The Alfred Hospital Melbourne Australia
University Heart Center Lübeck University Hospital Schleswig Holstein Lübeck Germany
University of Eastern Finland Institute of Clinical Medicine
Wellcome Wolfson Institute for Experimental Medicine Queen's University Belfast Belfast UK
Yong Loo Lin School of Medicine National University of Singapore Singapore
See more in PubMed
Brooks SC, Clegg GR, Bray J, et al. Optimizing outcomes after out‐of‐hospital cardiac arrest with innovative approaches to public‐access defibrillation: A scientific statement from the international liaison committee on resuscitation. Circulation. 2022;145(13):e776‐e801. doi:10.1161/CIR.0000000000001013 PubMed DOI
Moulaert VR, Verbunt JA, van Heugten CM, Wade DT. Cognitive impairments in survivors of out‐of‐hospital cardiac arrest: a systematic review. Resuscitation. 2009;80(3):297‐305. PubMed
Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out‐of‐hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346(8):557‐563. doi:10.1056/NEJMoa003289 PubMed DOI
Group HaCaS . Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549‐556. doi:10.1056/NEJMoa012689 PubMed DOI
Nielsen N, Wetterslev J, Cronberg T, et al. Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med. 2013;369(23):2197‐2206. doi:10.1056/NEJMoa1310519 PubMed DOI
Dankiewicz J, Cronberg T, Lilja G, et al. Hypothermia versus normothermia after out‐of‐hospital cardiac arrest. N Engl J Med. 2021;384(24):2283‐2294. doi:10.1056/NEJMoa2100591 PubMed DOI
Holgersson J, Meyer MAS, Dankiewicz J, et al. Hypothermic versus normothermic temperature control after cardiac arrest. NEJM Evid. 2022;1(11):EVIDoa2200137. doi:10.1056/EVIDoa2200137 PubMed DOI
Nolan JP, Sandroni C, Böttiger BW, et al. European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post‐resuscitation care. Intensive Care Med. 2021;47(4):369‐421. doi:10.1007/s00134-021-06368-4 PubMed DOI PMC
Sandroni C, Nolan JP, Andersen LW, et al. ERC‐ESICM guidelines on temperature control after cardiac arrest in adults. Intensive Care Med. 2022;48(3):261‐269. doi:10.1007/s00134-022-06620-5 PubMed DOI
Panchal AR, Bartos JA, Cabañas JG, et al. Part 3: adult basic and advanced life support: 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2020;142(16_suppl_2):S366‐S468. doi:10.1161/cir.0000000000000916 PubMed DOI
Granfeldt A, Holmberg MJ, Nolan JP, Soar J, Andersen LW, International Liaison Committee on Resuscitation (ILCOR) Advanced Life Support Task Force . Targeted temperature management in adult cardiac arrest: systematic review and meta‐analysis. Resuscitation. 2021;167:160‐172. doi:10.1016/j.resuscitation.2021.08.040 PubMed DOI
Nielsen N, Friberg H, Gluud C, et al. Hypothermia after cardiac arrest should be further evaluated–A systematic review of randomised trials with meta‐analysis and trial sequential analysis. Int J Cardiol. 2011;151(3):333‐341. doi:10.1016/j.ijcard.2010.06.008 PubMed DOI
Fernando SM, Di Santo P, Sadeghirad B, et al. Targeted temperature management following out‐of‐hospital cardiac arrest: a systematic review and network meta‐analysis of temperature targets. Intensive Care Med. 2021;47(10):1078‐1088. doi:10.1007/s00134-021-06505-z PubMed DOI
Aneman A, Frost S, Parr M, Skrifvars MB. Target temperature management following cardiac arrest: a systematic review and Bayesian meta‐analysis. Crit Care. 2022;26(1):58. doi:10.1186/s13054-022-03935-z PubMed DOI PMC
Behringer W, Böttiger BW, Biasucci DG, et al. Temperature control after successful resuscitation from cardiac arrest in adults: a joint statement from the European Society for Emergency Medicine (EUSEM) and the European Society of Anaesthesiology and Intensive Care (ESAIC). Eur J Emerg Med. 2024;31(2):86‐89. doi:10.1097/mej.0000000000001106 PubMed DOI PMC
Wass CT, Lanier WL, Hofer RE, Scheithauer BW, Andrews AG. Temperature changes of > or = 1 degree C alter functional neurologic outcome and histopathology in a canine model of complete cerebral ischemia. Anesthesiology. 1995;83(2):325‐335. doi:10.1097/00000542-199508000-00013 PubMed DOI
Baena RC, Busto R, Dietrich WD, Globus MYT, Ginsberg MD. Hyperthermia delayed by 24 hours aggravates neuronal damage in rat hippocampus following global ischemia. Neurology. 1997;48(3):768‐773. doi:10.1212/wnl.48.3.768 PubMed DOI
Zeiner A, Holzer M, Sterz F, et al. Hyperthermia after cardiac arrest is associated with an unfavorable neurologic outcome. Arch Intern Med. 2001;161(16):2007‐2012. doi:10.1001/archinte.161.16.2007 PubMed DOI
Nielsen N, Sunde K, Hovdenes J, et al. Adverse events and their relation to mortality in out‐of‐hospital cardiac arrest patients treated with therapeutic hypothermia. Crit Care Med. 2011;39(1):57‐64. doi:10.1097/CCM.0b013e3181fa4301 PubMed DOI
Dietrichs ES, McGlynn K, Allan A, et al. Moderate but not severe hypothermia causes pro‐arrhythmic changes in cardiac electrophysiology. Cardiovasc Res. 2020;116(13):2081‐2090. doi:10.1093/cvr/cvz309 PubMed DOI PMC
Emslie‐Smith D. Changes in the electrocardiogram during preoperative hypothermia in man. Australas Ann Med. 1956;5(1):62‐67. doi:10.1111/imj.1956.5.1.62 PubMed DOI
von Kaulla K. Is 37 degree C, the optimal clotting temperature for human blood? Acta Haematol. 1961;25:56‐61. doi:10.1159/000206511 PubMed DOI
Valeri CR, MacGregor H, Cassidy G, Tinney R, Pompei F. Effects of temperature on bleeding time and clotting time in normal male and female volunteers. Crit Care Med. 1995;23(4):698‐704. doi:10.1097/00003246-199504000-00019 PubMed DOI
Iba T, Connors JM, Levi M, Levy JH. Heatstroke‐induced coagulopathy: biomarkers, mechanistic insights, and patient management. eClinMed. 2022;44:101276. doi:10.1016/j.eclinm.2022.101276 PubMed DOI PMC
Olai H, Thornéus G, Watson H, et al. Meta‐analysis of targeted temperature management in animal models of cardiac arrest. Intensive Care Med Exp. 2020;8(1):3. doi:10.1186/s40635-019-0291-9 PubMed DOI PMC
Holm A, Reinikainen M, Kurola J, et al. Factors associated with fever after cardiac arrest: A post‐hoc analysis of the FINNRESUSCI study. Acta Anaesthesiol Scand. 2024;68(5):635‐644. doi:10.1111/aas.14387 PubMed DOI
Hassager C, Schmidt H, Møller JE, et al. Duration of device‐based fever prevention after cardiac arrest. N Engl J Med. 2023;388(10):888‐897. doi:10.1056/NEJMoa2212528 PubMed DOI
Greer DM, Helbok R, Badjatia N, et al. Fever prevention in patients with acute vascular brain injury: the INTREPID randomized clinical trial. JAMA. 2024;332:1525‐1534. doi:10.1001/jama.2024.14745 PubMed DOI PMC
Holgersson J, Ceric A, Sethi N, Nielsen N, Jakobsen JC. Fever therapy in febrile adults: systematic review with meta‐analyses and trial sequential analyses. BMJ. 2022;378:e069620. doi:10.1136/bmj-2021-069620 PubMed DOI PMC
Järpestam S, Martinell L, Rylander C, Lilja L. Post‐cardiac arrest intensive care in Sweden: A survey of current clinical practice. Acta Anaesthesiol Scand. 2023;67(9):1249‐1255. doi:10.1111/aas.14298 PubMed DOI
Skrifvars MB, Kurola J. The 2022 Finnish current care guidelines for cardiopulmonary resuscitation recommend avoiding fever and not mild therapeutic hypothermia in unconscious patients after cardiac arrest. Acta Anaesthesiol Scand. 2022;66(4):427‐429. doi:10.1111/aas.14027 PubMed DOI
Butcher NJ, Monsour A, Mew EJ, et al. Guidelines for reporting outcomes in trial protocols: the SPIRIT‐outcomes 2022 extension. JAMA. 2022;328(23):2345‐2356. doi:10.1001/jama.2022.21243 PubMed DOI
Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. doi:10.1136/bmj.c332 PubMed DOI PMC
Kahan BC, Hall SS, Beller EM, et al. Reporting of factorial randomized trials: extension of the CONSORT 2010 statement. JAMA. 2023;330(21):2106‐2114. doi:10.1001/jama.2023.19793 PubMed DOI PMC
Wijdicks EFM, Bamlet WR, Maramattom BV, Manno EM, McClelland RL. Validation of a new coma scale: the FOUR score. Ann Neurol. 2005;58(4):585‐593. doi:10.1002/ana.20611 PubMed DOI
Sandroni C, Cariou A, Cavallaro F, et al. Prognostication in comatose survivors of cardiac arrest: an advisory statement from the European Resuscitation council and the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40(12):1816‐1831. doi:10.1007/s00134-014-3470-x PubMed DOI PMC
Cook D, Lauzier F, Rocha MG, Sayles MJ, Finfer S. Serious adverse events in academic critical care research. Cmaj. 2008;178(9):1181‐1184. doi:10.1503/cmaj.071366 PubMed DOI PMC
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis‐3). JAMA. 2016;315(8):801‐810. doi:10.1001/jama.2016.0287 PubMed DOI PMC
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329(10):673‐682. doi:10.1056/nejm199309023291001 PubMed DOI
Haywood K, Whitehead L, Nadkarni VM, et al. COSCA (Core outcome set for cardiac arrest) in adults: an advisory statement from the international liaison committee on resuscitation. Resuscitation. 2018;127:147‐163. doi:10.1016/j.resuscitation.2018.03.022 PubMed DOI
Haywood K, Whitehead L, Nadkarni VM, et al. COSCA (Core outcome set for cardiac arrest) in adults: an advisory statement from the international liaison committee on resuscitation. Circulation. 2018;137(22):e783‐e801. doi:10.1161/cir.0000000000000562 PubMed DOI
Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five‐level version of EQ‐5D (EQ‐5D‐5L). Qual Life Res. 2011;20(10):1727‐1736. doi:10.1007/s11136-011-9903-x PubMed DOI PMC
Olsen MH, Jensen AKG, Dankiewicz J, et al. Interactions in the 2×2×2 factorial randomised clinical STEPCARE trial and the potential effects on conclusions: a protocol for a simulation study. Trials. 2022;23(1):889. doi:10.1186/s13063-022-06796-7 PubMed DOI PMC
Reade MC, Bass F, Howe B, Seppelt I, Shehabi Y. Considerations for co‐enrolment in randomised controlled effectiveness trials in critical care: the SPICE‐8 co‐enrolment guidelines. Crit Care Resusc. 2017;19(2):110‐114. PubMed
Nielsen N, Hovdenes J, Nilsson F, et al. Outcome, timing and adverse events in therapeutic hypothermia after out‐of‐hospital cardiac arrest. Acta Anaesthesiol Scand. 2009;53(7):926‐934. doi:10.1111/j.1399-6576.2009.02021.x PubMed DOI
Pareek N, Kordis P, Beckley‐Hoelscher N, et al. A practical risk score for early prediction of neurological outcome after out‐of‐hospital cardiac arrest: MIRACLE2. Eur Heart J. 2020;41(47):4508‐4517. doi:10.1093/eurheartj/ehaa570 PubMed DOI
World Medical Association . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191‐2194. doi:10.1001/jama.2013.281053 PubMed DOI
Lan KKG, Demets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70(3):659‐663. doi:10.1093/biomet/70.3.659 DOI
Garcia RA, Girotra S, Jones PG, et al. Variation in out‐of‐hospital cardiac arrest survival across emergency medical service agencies. Circ Cardiovasc Qual Outcomes. 2022;15(6):e008755. doi:10.1161/circoutcomes.121.008755 PubMed DOI PMC